Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Wired
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs. A new British startup believes that artificial intelligence is the key to speedrunning the slow and temperamental process of drug design.
Summary drawn from Wired's own description of the story.